NEUE — Neuehealth Cashflow Statement
0.000.00%
Last trade - 00:00- $43.10m
- $95.50m
- $1.16bn
- 20
- 56
- 42
- 34
Annual cashflow statement for Neuehealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -125 | -248 | -1,185 | -1,360 | -1,266 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.533 | 8.12 | 8.45 | 382 | 675 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 115 | 175 | 1,249 | 1,160 | -2,157 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Change in Policy Benefits/Liabilities | |||||
| Cash from Operating Activities | -8.21 | -57.2 | 82.1 | 234 | -2,727 |
| Capital Expenditures | -0.793 | -6.47 | -30.4 | -27.4 | -2.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -93.8 | -683 | -522 | -402 | 1,123 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -94.6 | -690 | -553 | -430 | 1,120 |
| Financing Cash Flow Items | — | — | -10.1 | -4.31 | -16.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 424 | 712 | 1,044 | 1,066 | 49.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 321 | -34.5 | 573 | 871 | -1,557 |